We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Mucins in cancer: function, prognosis and therapy.
- Authors
Kufe, Donald W
- Abstract
Epithelia are protected from adverse conditions by a mucous barrier. The secreted and transmembrane mucins that constitute the mucous barrier are largely unrecognized as effectors of carcinogenesis. However, both types of mucins are intimately involved in inflammation and cancer. Moreover, diverse human malignancies overexpress transmembrane mucins to exploit their role in signalling cell growth and survival. Mucins have thus been identified as markers of adverse prognosis and as attractive therapeutic targets. Notably, the findings that certain transmembrane mucins induce transformation and promote tumour progression have provided the experimental basis for demonstrating that inhibitors of their function are effective as anti-tumour agents in preclinical models.
- Publication
Nature reviews. Cancer, 2009, Vol 9, Issue 12, p874
- ISSN
1474-1768
- Publication type
Journal Article
- DOI
10.1038/nrc2761